MARKET

KMDA

KMDA

Kamada Ltd
NASDAQ
7.24
0.00
0.00%
After Hours: 7.24 0 0.00% 16:10 06/09 EDT
OPEN
7.28
PREV CLOSE
7.24
HIGH
7.31
LOW
7.09
VOLUME
19.59K
TURNOVER
--
52 WEEK HIGH
9.08
52 WEEK LOW
6.31
MARKET CAP
417.65M
P/E (TTM)
20.80
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KMDA last week (0601-0605)?
Weekly Report · 1d ago
Kamada: Undervalued, Yet Execution Risks Keep It A Hold
Seeking Alpha · 06/02 18:11
Kamada Receives FDA Approval For In-House Rabies Virus Neutralization Testing Laboratory
NASDAQ · 06/01 12:37
Kamada gets FDA approval for Rapid Fluorescent Focus Inhibition Test laboratory
TipRanks · 06/01 11:59
Kamada Wins FDA Nod for New In‑House Rabies Antibody Testing Lab
TipRanks · 06/01 11:31
Kamada Announces FDA Approval Of New In-House Rapid Fluorescent Focus Inhibition Test Laboratory
Benzinga · 06/01 11:05
Weekly Report: what happened at KMDA last week (0525-0529)?
Weekly Report · 06/01 09:39
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
Barchart · 06/01 06:00
More
About KMDA
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Webull offers Kamada Ltd stock information, including NASDAQ: KMDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KMDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KMDA stock methods without spending real money on the virtual paper trading platform.